Missing 4th QTR earnings BIG































Not just the street.. there are very few internal folks who believe that we can have a decent product launch.. most folks have figured out that the only reason we acquired pipeline assets was in the hope that we will get a boost on our PE multiple like other biotech stocks if we show some promise in the pipeline.

The failed launches will continue....if those products ever launch